BRAIN.Q, an emerging leader in AI-driven Brain Longevity Therapeutics today announced promising results from its U.S. multicenter randomized controlled study – EMAGINE, suggesting that treatment with its AI-powered electromagnetic field therapy may lead to meaningful clinical benefits and a substantial reduction in disability following a stroke. These promising results align with the encouraging findings observed in an earlier randomized controlled pilot trial done with BRAIN.Q’s therapy, announced in 2021.

Read more here.